THC:CBD Effectively Reduces Severe Spasticity in Treatment-Resistant …
2019年5月9日 · PHILADELPHIA — Real-life outcomes support the long-term effectiveness of tetrahydrocannabinol and cannabidiol (THC:CBD) to improve spasticity in patients with …
Cannabis Extract Improves Spasticity Without Increasing Weakness …
2020年12月31日 · Nabiximols, a complex botanical medication formulated from extracts of the cannabis plant, improves spasticity in patients with multiple sclerosis (MS) without producing …
Evidence for the efficacy and effectiveness of THC-CBD …
Spasticity, one of the main symptoms of multiple sclerosis (MS), can affect more than 80% of MS patients during the course of their disease and is often not treated adequately. δ-9 …
Cannabinoids in the management of spasticity associated with …
In this study we highlight the main findings reported in literature about the relevance of cannabinoid drugs in the management and treatment of MS. An increasing body of evidence …
Cannabinoids for spasticity in patients with multiple sclerosis: A ...
Nowadays, cannabinoids are used for spasticity control in patients with MS, while the efficacy and safety are not clearly understood. So, we designed this systematic review and meta-analysis …
Whole plant cannabis extracts in the treatment of spasticity in ...
2009年12月4日 · We found evidence that combined THC and CBD extracts may provide therapeutic benefit for MS spasticity symptoms. Although some objective measures of …
Cannabinoids for the treatment of spasticity - Nielsen - 2019 ...
Analysis at 12 months found self-reported (patient-rated) improvement in spasticity with dronabinol and THC:CBD extract, which was confirmed objectively by the Ashworth score in …
THC:CBD Spray and MS Spasticity Symptoms: Data from Latest …
2014年1月22日 · New clinical experience with 9-delta-tetrahydocannabinol (THC) and cannabidiol (CBD) oromucosal spray (Sativex®) involving more than an additional 1,000 patients with MS …
Clinical experiences with cannabinoids in spasticity management …
2014年6月1日 · Spasticity is a common symptom among patients with multiple sclerosis (MS). This study aims to assess the effectiveness and safety of the combination of delta-9 …
Sativex Provides Consistent Relief for Treatment-resistant MS...
2020年3月12日 · Sativex (nabiximols), a THC:CBD oral spray, consistently relieves the pain and severity of treatment-resistant spasticity in multiple sclerosis (MS) patients, according to a …
- 某些结果已被删除